• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Pulmonary Arterial Hypertension Life Expectancy & Survival Rates

March 16, 2018 By Dr. Jeremy Feldman

high risk vs. low risk life expectancy in Pulmonary Hypertension

The treatment for Pulmonary Arterial Hypertension has come a long way since the mid 1990’s when Flolan was first approved.  There has been an explosion of new medications that have dramatically altered how we treat patients.  We no longer sequentially add therapies to most of our patients.  Rather, we often start two or even three different therapies as part of an initial … [Read more...]

What if I’m Not Getting Better?

July 3, 2017 By Dr. Jeremy Feldman

PH related to lung disease

Pulmonary arterial hypertension is a progressive disease affecting the blood vessels of the lungs (pulmonary arteries to be specific). Without treatment, the right ventricle of the heart starts to struggle with pumping blood through the lungs. This leads to fatigue, shortness of breath, swelling, fainting and other symptoms. We are fortunate to have many medications that now … [Read more...]

Why I Am A Pulmonary Hypertension Specialist

November 18, 2014 By Dr. Jeremy Feldman

Dr. Jeremy Feldman PAH Specialist

November is PAH awareness month. It seems fitting to reflect on my career choice to specialize in the treatment of patients with PAH. … [Read more...]

November 18th is the First Ever CTEPH Awareness Day

November 13, 2014 By Dr. Jeremy Feldman

CT Angiogram CTEPH

As part of PAH Awareness Month this year November 18th has been assigned as the official CTEPH Awareness Day. This will be the first ever awareness day focused on CTEPH or chronic thromboembolic pulmonary hypertension. … [Read more...]

November is Pulmonary Hypertension Awareness Month

October 24, 2014 By Dr. Jeremy Feldman

PAH Awareness

November is the official Pulmonary Hypertension Awareness month. It is important to raise awareness about Pulmonary Hypertension in every community. Heightened awareness leads to better care for PAH patients, increased referrals to pulmonary hypertension specialty centers, decreased time to diagnosis, and increased funds for research for new treatments and potentially a cure. … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Blood tests to monitor PH patients

Sickle Cell and Pulmonary Hypertension

By Dr. Jeremy Feldman

What is Sickle Cell Disease? Sickle Cell Disease is a genetic disorder of the red blood cells. It is autosomal

PAH patient story

My Pulmonary Hypertension Journey

By Dr. Jeremy Feldman

Every patient I have met in our pulmonary hypertension clinic has one thing in common; their journey to diagnosis and

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives